DNA priming E and NS1 constructs-homologous proteins boosting immunization strategy to improve immune response against dengue in mice

Viral Immunology

Volumn 18, Issue 4, 2005, Pages 709-721

  Mellado Sánchez, Gabriela ^a,b   García Cordero, Julio ^a   Luria Pérez, Rosendo ^a   Lázaro Olan, Lucero ^a   Santos Argumedo, Leopoldo ^a   Gutiérrez Castañeda, Benito ^b   Estrada García, Iris ^b   Cedillo Barrón, Leticia ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; DENGUE VIRUS E PROTEIN; EPITOPE; GLUTATHIONE TRANSFERASE; NEUTRALIZING ANTIBODY; NONSTRUCTURAL PROTEIN 1; PLASMID DNA; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DESIGN; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; RECOMBINANT PLASMID; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; GENETIC VECTORS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PLASMIDS; VACCINATION; VACCINES, DNA; VACCINES, SUBUNIT; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES;

ANIMALIA; DENGUE VIRUS;

EID: 29844446136     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2005.18.709     Document Type: Article

References (35)

1. Berzofsky, J.A., J.D. Ahlers, and I.M. Belyakov. 2001. Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 1:209-219.
2. Cedillo-Barron, L., M. Foster-Cuevas, G.J. Belsham, F. Lefevre, and R.M. Parkhouse. 2001. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J. Gen. Virol. 82:1713-1724.
3. Cedillo-Barron, L., M. Foster-Cuevas, A. Cook, B. Gutierrez-Castaneda, S. Kollnberger, F. Lefevre, and R.M. Parkhouse. 2003. Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine. Vaccine 21:4261-4269.
4. Chambers, T.J., C.S. Hahn, R. Galler, and C.M. Rice. 1990. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44:649-688.
5. Falgout, B., M. Bray, J.J. Schlesinger, and C.J. Lai. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64:4356-4363.
6. Gubler, D.J. 2002. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 10:100-103.
7. Gurunathan, S., C.Y. Wu, B.L. Freidag, and R.A. Seder. 2000. DNA vaccines: a key for inducing long-term cellular immunity. Curr. Opin. Immunol. 12:442-447.
8. Guzman, M.G. and G. Kouri. 2002. Dengue: an update. Lancet Infect. Dis. 2:33-42.
9. Halstead, S.B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
10. Halstead, S.B. and J. Deen. 2002. The future of dengue vaccines. Lancet 19;360:1243-1245.
11. Katrak, K., B.P. Mahon, W.C. Jones, S. Brautigam, and K.H. Mills. 1992. Preparative separation of foreign antigens for highly efficient presentation to T cells in vitro. J. Immunol. Methods 156:247-254.
12. Kochel, T., S.J. Wu, K. Raviprakash, P. Hobart, S. Hoffman, K. Porter, and C. Hayes. 1997. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine 15:547-552.
13. Kochel, T.J., K. Raviprakash, C.G. Hayes, D.M. Watts, K.L. Russell, A.S. Gozalo, I.A. Phillips, D.F. Ewing, G.S. Murphy, and K.R. Porter. 2000. A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys. Vaccine 18:3166-3173.
14. Konishi, E., N. Ajiro, C. Nukuzuma, P.W. Mason, and I. Kurane. 2003. Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Vaccine 21:3675-3683.
15. Konishi, E., M. Yamaoka, I. Kurane, and P.W. Mason. 2000. A DNA vaccine expressing dengue type 2 virus pre-membrane and envelope genes induces neutralizing antibody and memory B cells in mice. Vaccine 18:1133-1139.
16. Lin, Y.L., L.K. Chen, C.L. Liao, C.T. Yeh, S.H. Ma, J.L. Chen, Y.L. Huang, S.S. Chen, and H.Y. Chiang. 1998. DNA immunization with Japanese encephalitis virus non-structural protein NS1 elicits protective immunity in mice. J. Virol. 72:191-200.
17. Lu, Y., K. Raviprakash, I.C. Leao, P.R. Chikhlikar, D. Ewing, A. Anwar, C. Chougnet, G. Murphy, C.G. Hayes, T.J. August, and E.T. Marques, Jr. 2003. Dengue 2 PreME/LAMP chimera largeted to the MHC class II compartment elicits long-lasting neutralizing antibodies. Vaccine 21:2178-2189.
18. Megret, F., J.P. Hugnot, A. Falconar, M. K. Gentry, D.M. Morens, J.M. Murray, J.J. Schlesinger, P.J. Wright, P. Young, M.H. Van Regenmortel, and V. Deubel. 1992. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 187:480-491.
19. Men, R., L. Wyatt, I. Tokimatsu, S. Arakaki, G. Shameem, R. Elkins, R. Charlock, B. Moss, and C.J. Lai. 2000. Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge. Vaccine 18:3113-3122.
20. Morens, D.M., S.B. Halstead, P.M. Repik, R. Putvatana, and N. Raybourne. 1985. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J. Clin. Microbiol. 22:250-254.
21. Porter, K.R., T.J. Kochel, S.J. Wu, K. Raviprakash, I. Phillips, and C.G. Hayes. 1998. Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses. Arch. Virol. 143:997-1003.
22. Putnak, R., J. Fuller, L. VanderZanden, B.L. Innis, and D.W. Vaughn. 2003. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes. Am. J. Trop. Med. Hyg. 68:469-476.
23. Putnak, R., K. Porter, and C. Schmaljohn. 2003. DNA vaccines for flaviviruses. Adv. Virus Res. 61:445-468.
24. Raviprakash, K., D. Ewing, M. Simmons, K.R. Porter, T.R. Jones, C.G. Hayes, R. Stout, and O.S. Murphy. 2003. Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys. Virology 315: 345-352.
25. Raviprakash, K., E. Marques, D. Ewing, Y. Lu, I. Phillips, K.R. Porter, T.J. Kochel, T.J. August, C.G. Hayes, and G.S. Murphy. 2001. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Virology 290: 74-82.
26. Raviprakash, K., K.R. Porter, T.J. Kochel, D. Ewing, M. Simmons, I. Phillips, G.S. Murphy, W.R. Weiss, and C.G. Hayes. 2000. Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques. J. Gen. Virol. 81:1659-1667.
27. Schlesinger, J.J., M.W. Brandriss, C. B. Cropp, and T.P. Monath. 1986. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J. Virol. 60:1153-1155.
28. Schlesinger, J.J., M.W. Brandriss, and E.E. Walsh. 1987. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J. Gen. Virol. 68:853-857.
29. Schlesinger, J.J., M. Foltzer, and S. Chapman. 1993. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192:132-141.
30. Sharma, A.K. and G.K. Khuller. 2001. DNA vaccines: future strategies and relevance to intracellular pathogens. Immunol. Cell Biol. 79:537-546.
31. Simmons, M., G.S. Murphy, T. Kochel, K. Raviprakash, and C.G. Hayes. 2001. Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine. Am. J. Trop. Med. Hyg. 65:420-426.
32. Srivastava, A.K., J.R. Putnak, R.L. Warren, and C.H. Hoke, Jr. 1995. Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection. Vaccine 13:1251-1258.
33. Timofeev, A.V., V.M. Butenko, and J.R. Stephenson. 2004. Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus. Virus Genes 28:85-97.
34. Woodland, D.L. 2004. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol. 25:98-104.
35. Wu, S.F., C.L. Liao, Y.L. Lin, C.T. Yeh, L.K. Chen, Y.F. Huang, H.Y. Chou, J.L. Huang, M.F. Shaio, and H.K. Sytwu. 2003. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Vaccine 21:3919-3929.